Actively Recruiting

Phase 2
Age: 18Years +
FEMALE
NCT06705075

Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE

Led by Thomas Jefferson University · Updated on 2025-04-10

80

Participants Needed

1

Research Sites

87 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study goals are to determine the patterns of uterine fibroid vascularity pre and post UAE using CEUS resulting in an alternative to gadolinium-enhanced MRI that is less expensive, has less contra-indications and side effects, is real time, and noninvasive helping physicians to evaluate the result of UAE procedures. Also, this study will evaluate uterine fibroid pressures using SHAPE, comparing the results with normal myometrium tissue in order to determine its characteristics and tissue differences, which we believe will lead to the development of a new biomarker for the diagnosis and treatment of uterine fibroids.

CONDITIONS

Official Title

Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Be a female diagnosed with endometrial cancer and scheduled for UAE.
  • Be over the age of 18 years.
  • If of child-bearing potential, must have a negative pregnancy test.
  • Be conscious and able to comply with study procedures.
  • Have read and signed the IRB approved consent form for participating in the study.
Not Eligible

You will not qualify if you...

  • Females who are pregnant or nursing.
  • Received an investigational drug in the 30 days before study drug administration or will receive one within 72 hours afterwards.
  • Medically unstable, seriously or terminally ill, or with unpredictable clinical course.
  • On life support or in a critical care unit.
  • Clinically unstable cardiac arrhythmias such as recurrent ventricular tachycardia.
  • Recent cerebral hemorrhage.
  • Underwent surgery within 24 hours prior to the study sonographic examination.
  • Congenital heart defects.
  • Known allergy to Definity.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Thomas Jefferson University

Philadelphia, Pennsylvania, United States, 19107

Actively Recruiting

Loading map...

Research Team

P

Priscilla Machado, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here